Marsden Eye Specialists – LIVE Webinar                  “Glaucoma Surgery- Are we there yet?” by Dr Ashish Agar “Glaucoma Medical Management and SLT” by Dr Samuel Dance


This event was held on
Wednesday, September 23, 2020

What time?

06:30 PM AEST - 08:00 PM AEST



About the Webcast

Marsden Eye Specialists cordially invite you to an Optometrist Educational Seminar on 

23 September 2020 at 6:30 PM. 

This is a 4 CPD points Activity accredited by Eye on CPD, Optometry Australia (ID: 90001802)

Dr Ashish Agar - “Glaucoma Surgery- Are we there yet?

  • Understand the role of conventional surgery
  • What is the promise of MIGS?
  • Be aware of new alternative technologies

Dr Samuel Dance -  “Glaucoma Medical Management and SLT” 

  • Current topical medications for glaucoma and management algorithms
  • New/imminent glaucoma medications
  • SLT - a non-invasive alternative to medication and evidence for use

Register Today!

The Event Registration is closed, please contact your Event Host.

For technical assistance, please phone Redback Connect on 1800 733 416.

Click here to test your system before the webinar.

Dr Ashish Agar MBBS, PhD, FRANZCO Cataract, Glaucoma and General Ophthalmology - Partner

Dr Ashish Agar is an Ophthalmologist who specialises in Glaucoma, Cataract and general Ophthalmology. He is currently a partner of Marsden Eye Specialists and an Academic Glaucoma Specialist at the Prince of Wales Hospital and Sydney Eye Hospital. He is a Senior Lecturer in the Department of Ophthalmology at UNSW and a Consultant to the Guide Dogs Centre For Eye Health. Dr Agar is passionately involved in Indigenous and remote community eye care as a Medical Director of the Outback Eye Service in western NSW, and is the Chair of the RANZCO Indigenous Committee.

Dr Samuel Dance MBBS, MS (Surgical Anatomy), FRANZCO Cataract Surgery, Glaucoma, Medical Retina and General Ophthalmology

Dr Samuel Dance is a comprehensive general ophthalmologist with sub-specialty training in Cataract and Glaucoma surgery, and medical conditions of the retina including Diabetic Retinopathy, Macular Degeneration and Vein occlusions.
He has been a reviewer for the Journal of Glaucoma, lectured at both the University of Sydney, and University of New South Wales, and been an investigator for multiple international clinical trials assessing innovative ocular therapies. He has been appointed to the Ophthalmology Liaison Committee at Glaucoma Australia and is a fellow of the Royal Australian & New Zealand College of Ophthalmologists.